Symbol: |
MED15
|
Description: |
mediator complex subunit 15 [Source:HGNC Symbol;Acc:14248]
|
Location: |
Chr22:20850200-20941919[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:232
Gene |
Compound |
Gen_sig |
Exp_pattern |
MED15 |
NSC 720375 |
0.036 |
Up |
MED15 |
NSC 720425 |
0.001 |
Up |
MED15 |
NSC 720433 |
0.024 |
Up |
MED15 |
N-(6'-Chrysenyl)-4-(1'-piperidinyl)-D-2,3-dioxalono-butane-1 ,4-dicarboximide |
0.049 |
Up |
MED15 |
8-chloro-3-(4-methylphenylamino)-7-methoxycarbonyl-1,2,4-tri azolo[4,3-b][1,2,4]benzodithiazine 5,5-dioxide |
0.007 |
Up |
MED15 |
NSC 720666 |
0.005 |
Up |
MED15 |
NSC 720794 |
0.008 |
Up |
MED15 |
NSC 721875 |
0.011 |
Down |
MED15 |
NSC 722222 |
0.006 |
Up |
MED15 |
NSC 722398 |
0.012 |
Up |
MED15 |
(Thiopen-2-ylmethylene-hydrazinocarbonylmethylsulfanyl) acetic acid(thiopen-2-ylmethylene)-hydrazide |
0.009 |
Up |
MED15 |
(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.04,13.08,13]hexadecane |
0.021 |
Up |
MED15 |
6-[3-(Bis-hydroxyethylamino)-1-propyl]-5,6-dihydro-2,3-~ dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride |
0.026 |
Up |
MED15 |
6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride |
0.041 |
Up |
MED15 |
NSC 726373 |
0.03 |
Down |
Expression pattern: Sensitivity / Resistance
Total:16 Current:14
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:27
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|